[1] Colby SL, Ortman JM. Projections of the size and composition of the U.S. population: 2014 to 2060: Current Population Reports. Washington, D.C., U.S. Census Bureau, 2014, pp 1-13.

[2] Yancey AK, Ortega AN, Kumanyika SK. Effective recruitment and retention of minority research participants. Annu Rev Public Health 2006;27:1-28.

[3] Napoles AM, Chadiha LA, Resource Centers for Minority Aging R. Advancing the science of recruitment and retention of ethnically diverse populations. Gerontologist 2011;51 Suppl 1:S142-146.

[4] McNutt DM, Holdsworth MT, Wong C, Hanrahan JD, Winter SS. Rasburicase for the management of tumor lysis syndrome in neonates. Ann Pharmacother 2006;40:1445-1450.

[5] Stock W, Douer D, DeAngelo DJ, Arellano M, Advani A, Damon L, Kovacsovics T, Litzow M, Rytting M, Borthakur G, Bleyer A. Prevention and management of asparaginase/pegasparaginase- associated toxicities in adults and older adolescents: Recommendations of an expert panel. Leuk Lymphoma 2011;52:2237-2253.

[6] Kamali F. Genetic influences on the response to warfarin. Curr Opin Hematol 2006;13:357-361.

[7] Wall TL, Luczak SE, Hiller-Sturmhofel S. Biology, genetics, and environment: Underlying factors influencing alcohol metabolism. Alcohol Res 2016;38:59-68.

[8] Hamilton BK, Rybicki L, Sekeres M, Kalaycio M, Hanna R, Sobecks R, Dean R, Duong H, Hill BT, Bolwell B, Copelan E. Racial differences in allogeneic hematopoietic cell transplantation outcomes among african americans and whites. Bone Marrow Transplant 2015;50:834-839.

[9] Hunger SP, Lu X, Devidas M, Camitta BM, Gaynon PS, Winick NJ, Reaman GH, Carroll WL. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: A report from the children's oncology group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30:1663-1669.

[10] Gill AA, Enewold L, Zahm SH, Shriver CD, Stojadinovic A, McGlynn KA, Zhu K. Colon cancer treatment: Are there racial disparities in an equal-access healthcare system? Dis Colon Rectum 2014;57:1059-1065.

[11] May FP, Almario CV, Ponce N, Spiegel BM. Racial minorities are more likely than whites to report lack of provider recommendation for colon cancer screening. Am J Gastroenterol 2015;110:1388-1394.

[12] Harvey RC, Mullighan CG, Wang X, Dobbin KK, Davidson GS, Bedrick EJ, Chen IM, Atlas SR, Kang H, Ar K, Wilson CS, Wharton W, Murphy M, Devidas M, Carroll AJ, Borowitz MJ, Bowman WP, Downing JR, Relling M, Yang J, Bhojwani D, Carroll WL, Camitta B, Reaman GH, Smith M, Hunger SP, Willman CL. Identification of novel cluster groups in pediatric high-risk b-precursor acute lymphoblastic leukemia with gene expression profiling: Correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome. Blood 2010;116:4874-4884.

[13] Xu H, Cheng C, Devidas M, Pei D, Fan Y, Yang W, Neale G, Scheet P, Burchard EG, Torgerson DG, Eng C, Dean M, Antillon F, Winick NJ, Martin PL, Willman CL, Camitta BM, Reaman GH, Carroll WL, Loh M, Evans WE, Pui CH, Hunger SP, Relling MV, Yang JJ. Arid5b genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia. J Clin Oncol 2012;30:751-757.

[14] Yang JJ, Cheng C, Devidas M, Cao X, Fan Y, Campana D, Yang W, Neale G, Cox NJ, Scheet P, Borowitz MJ, Winick NJ, Martin PL, Willman CL, Bowman WP, Camitta BM, Carroll A, Reaman GH, Carroll WL, Loh M, Hunger SP, Pui CH, Evans WE, Relling MV. Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia. Nature genetics 2011;43:237-241.

[15] Mayfield JR, Czuchlewski DR, Gale GM, Matlawska-Wasowska K, Vasef MA, Nickl CK, Picket G, Ness SA, Winter SS. Integration of ruxolitinib into dose-intensified therapy targeted against a novel jak2 f694l mutation in b-precursor acute lymphoblastic leukemia. Pediatr Blood Cancer 2016;In Press

[16] Klein K, Lang T, Saussele T, Barbosa-Sicard E, Schunck WH, Eichelbaum M, Schwab M, UM Z. Genetic variability of cyp2b6 in populations of african and asian origin: Allele frequencies, novel functional variants, and possible implications for anti-hiv therapy with efavirenz. Pharmacogenetics and genomics 2005;15:861-873.

[17] Ford ME, Siminoff LA, Pickelsimer E, Mainous AG, Smith DW, Diaz VA, Soderstrom LH, Jefferson MS, Tilley BC. Unequal burden of disease, unequal participation in clinical trials: Solutions from african american and latino community members. Health Soc Work 2013;38:29-38.

[18] George S, Duran N, Norris K. A systematic review of barriers and facilitators to minority research participation among african americans, latinos, asian americans, and pacific islanders. Am J Public Health 2014;104:e16-31.

[19] Killien M, Bigby JA, Champion V, Fernandez-Repollet E, Jackson RD, Kagawa-Singer M, Kidd K, Naughton MJ, Prout M. Involving minority and underrepresented women in clinical trials: The national centers of excellence in women's health. J Womens Health Gend Based Med 2000;9:1061-1070.

[20] King J, JA A. Clinical impact of patient population differences and genomic variation in efavirenz therapy. . AIDS 2008;22:1709-1717.

[21] Shavers VL, Lynch CF, LF B. Knowledge of the tuskegee study and its impact on the willingness to participate in medical research studies. Journal of the National Medical Association 2000;92:663-672.

[22] Choi E, Heo GJ, Song Y, Han HR. Community health worker perspectives on recruitment and retention of recent immigrant women in a randomized clinical trial. Fam Community Health 2016;39:53-61.

[23] Nguyen D, Reardon LJ. The role of race and english proficiency on the health of older immigrants. Soc Work Health Care 2013;52:599-617.

[24] Vissandjee B, Desmeules M, Cao Z, Abdool S, Kazanjian A. Integrating ethnicity and migration as determinants of canadian women's health. BMC Womens Health 2004;4 Suppl 1:S32.

[25] Waisel DB. Vulnerable populations in healthcare. Curr Opin Anaesthesiol 2013;26:186-192.

[26] Flores G, Lin H, Walker C, Lee M, Portillo A, Henry M, Fierro M, Massey K. A cross-sectional study of parental awareness of and reasons for lack of health insurance among minority children, and the impact on health, access to care, and unmet needs. Int J Equity Health 2016;15:44.

[27] Kreider AR, French B, Aysola J, Saloner B, Noonan KG, Rubin DM. Quality of health insurance coverage and access to care for children in low-income families. Jama Pediatrics 2016;170:43-51.

[28] Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? Jama-Journal of the American Medical Association 2000;283:2701-2711.

[29] Townsley CA, Selby R, Siu LL. Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials. J Clin Oncol 2005;23:3112-3124.

[30] Cruz TH, Davis SM, FitzGerald CA, Canaca GF, Keane PC. Engagement, recruitment, and retention in a trans-community, randomized controlled trial for the prevention of obesity in rural american indian and hispanic children. J Prim Prev 2014;35:135- 149.

[31] Waheed W, Hughes-Morley A, Woodham A, Allen G, Bower P. Overcoming barriers to recruiting ethnic minorities to mental health research: A typology of recruitment strategies. BMC Psychiatry 2015;15:101.

[32] McMurdo ME, Roberts H, Parker S, Wyatt N, May H, Goodman C, Jackson S, Gladman J, O'Mahony S, Ali K, Dickinson E, Edison P, Dyer C, Age, Ageing Specialty Group NCCRN Improving recruitment of older people to research through good practice. Age Ageing 2011;40:659-665.

[33] Hodge FS, Weinmann S, Roubideaux Y. Recruitment of american indians and alaska natives into clinical trials. Ann Epidemiol 2000;10:S41-48.

[34] Caldwell PH, Hamilton S, Tan A, Craig JC. Strategies for increasing recruitment to randomised controlled trials: Systematic review. PLoS Med 2010;7:e1000368.

[35] Alexander GL, Divine GW, Couper MP, McClure JB, Stopponi MA, Fortman KK, Tolsma DD, Strecher VJ, Johnson CC. Effect of incentives and mailing features on online health program enrollment. Am J Prev Med 2008;34:382-388.

[36] Beydoun H, Saftlas AF, Harland K, Triche E. Combining conditional and unconditional recruitment incentives could facilitate telephone tracing in surveys of postpartum women. J Clin Epidemiol 2006;59:732-738.

[37] Kamb ML, Rhodes F, Hoxworth T, Rogers J, Lentz A, Kent C, MacGowen R, Peterman TA. What about money? Effect of small monetary incentives on enrollment, retention, and motivation to change behaviour in an hiv/std prevention counselling intervention. The project respect study group. Sex Transm Infect 1998;74:253-255.

[38] Walter JK, Burke JF, Davis MM. Research participation by low- income and racial/ethnic minority groups: How payment may change the balance. Clin Transl Sci 2013;6:363-371.

[39] Brueton VC, Stevenson F, Vale CL, Stenning SP, Tierney JF, Harding S, Nazareth I, Meredith S, Rait G. Use of strategies to improve retention in primary care randomised trials: A qualitative study with in-depth interviews. BMJ Open 2014;4:e003835.

[40] Trent M, Chung SE, Gaydos C, Frick KD, Anders J, Huettner S, Rothman R, Butz A. Recruitment of minority adolescents and young adults into randomised clinical trials: Testing the design of the technology enhanced community health nursing (tech-n) pelvic inflammatory disease trial. Eur Med J Reprod Health 2016;2:41-51.

[41] Paskett ED, Reeves KW, McLaughlin JM, Katz ML, McAlearney AS, Ruffin MT, Halbert CH, Merete C, Davis F, Gehlert S. Recruitment of minority and underserved populations in the united states: The centers for population health and health disparities experience. Contemp Clin Trials 2008;29:847-861.

[42] Sateren WB, Trimble EL, Abrams J, Brawley O, Breen N, Ford L, McCabe M, Kaplan R, Smith M, Ungerleider R, Christian MC. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol 2002;20:2109-2117.

[43] Williams M, Powers M, Yun YG, Foa E. Minority participation in randomized controlled trials for obsessive-compulsive disorder. J Anxiety Disord 2010;24:171-177.

[44] Ford JG, Howerton MW, Lai GY, Gary TL, Bolen S, Gibbons MC, Tilburt J, Baffi C, Tanpitukpongse TP, Wilson RF, Powe NR, Bass EB. Barriers to recruiting underrepresented populations to cancer clinical trials: A systematic review. Cancer 2008;112:228-242.

[45] Carter-Edwards L, Fisher JT, Vaughn BJ, Svetkey LP. Church rosters: Is this a viable mechanism for effectively recruiting african americans for a community-based survey? Ethn Health 2002;7:41-55.

[46] Orden SR, Dyer AR, Liu K. Recruiting young adults in an urban setting: The chicago cardia experience. Am J Prev Med 1990;6:176-182.

[47] Sullivan-Bolyai S, Bova C, Deatrick JA, Knafl K, Grey M, Leung K, Trudeau A. Barriers and strategies for recruiting study participants in clinical settings. West J Nurs Res 2007;29:486- 500.

[48] Durant RW, Davis RB, St George DM, Williams IC, Blumenthal C, Corbie-Smith GM. Participation in research studies: Factors associated with failing to meet minority recruitment goals. Ann Epidemiol 2007;17:634-642.

[49] Wendler D, Kington R, Madans J, Van Wye G, Christ-Schmidt H, Pratt LA, Brawley OW, Gross CP, Emanuel E. Are racial and ethnic minorities less willing to participate in health research? PLoS Med 2006;3:e19.

[50] Wright JT, Jr., Cushman WC, Davis BR, Barzilay J, Colon P, Egan D, Lucente T, Nwachuku C, Pressel S, Leenen FH, Frolkis J, Letterer R, Walsh S, Tobin JN, Deger GE, Group AR. The antihypertensive and lipid-lowering treatment to prevent heart attack trial (allhat): Clinical center recruitment experience. Control Clin Trials 2001;22:659-673.

[51] Ford JG, Howerton M. The science of recruiting minority populations to screening trials. Clin Trials 2004;1:341-342.

[52] UyBico SJ, Pavel S, Gross CP. Recruiting vulnerable populations into research: A systematic review of recruitment interventions. J Gen Intern Med 2007;22:852-863.

[53] Ejiogu N, Norbeck JH, Mason MA, Cromwell BC, Zonderman AB, Evans MK. Recruitment and retention strategies for minority or poor clinical research participants: Lessons from the healthy aging in neighborhoods of diversity across the life span study. Gerontologist 2011;51 Suppl 1:S33-45.

[54] Wilets I, O'Rourke M, Nassisi D. How patients and visitors to an urban emergency department view clinical research. Acad Emerg Med 2003;10:1081-1085.

[55] Keyzer JF, Melnikow J, Kuppermann M, Birch S, Kuenneth C, Nuovo J, Azari R, Oto-Kent D, Rooney M. Recruitment strategies for minority participation: Challenges and cost lessons from the power interview. Ethn Dis 2005;15:395-406.

[56] Corbie-Smith G, Moody-Ayers S, Thrasher AD. Closing the circle between minority inclusion in research and health disparities. Arch Intern Med 2004;164:1362-1364.

[57] Bolen S, Tilburt J, Baffi C, Gary TL, Powe N, Howerton M, Ford J, Lai G, Wilson R, Bass E. Defining "success" in recruitment of underrepresented populations to cancer clinical trials: Moving toward a more consistent approach. Cancer 2006;106:1197-1204.

[58] Blanton S, Morris DM, Prettyman MG, McCulloch K, Redmond S, Light KE, Wolf SL. Lessons learned in participant recruitment and retention: The excite trial. Phys Ther 2006;86:1520-1533.

[59] LaVeist TA, Nickerson KJ, Bowie JV. Attitudes about racism, medical mistrust, and satisfaction with care among african american and white cardiac patients. Med Care Res Rev 2000;57 Suppl 1:146-161.

[60] Wipke-Tevis DD, Pickett MA. Impact of the health insurance portability and accountability act on participant recruitment and retention. West J Nurs Res 2008;30:39-53.

[61] Blumenthal DS, Sung J, Coates R, Williams J, Liff J. Recruitment and retention of subjects for a longitudinal cancer prevention study in an inner-city black community. Health Serv Res 1995;30:197-205.

[62] Dennis BP, Neese JB. Recruitment and retention of african american elders into community-based research: Lessons learned. Arch Psychiatr Nurs 2000;14:3-11.

[63] Haozous EA, Neher C. Best practices for effective clinical partnerships with indigenous populations of north america (american indian, alaska native, first nations, metis, and inuit). Nurs Clin North Am 2015;50:499-508.

[64] Trickett EJ. Multilevel community-based culturally situated interventions and community impact: An ecological perspective. Am J Community Psychol 2009;43:257-266.

[65] Larkey LK, Staten LK, Ritenbaugh C, Hall RA, Buller DB, Bassford T, Altimari BR. Recruitment of hispanic women to the women's health initiative. The case of embajadoras in arizona. Control Clin Trials 2002;23:289-298.

[66] Larkey LK, Gonzalez JA, Mar LE, Glantz N. Latina recruitment for cancer prevention education via community based participatory research strategies. Contemp Clin Trials 2009;30:47-54.

[67] Page-Reeves J, Mishra SI, Niforatos J, Regino L, Bulten R. An integrated approach to diabetes prevention: Anthropology, public health, and community engagement. Qual Rep 2013;18:1-22.

[68] Wallerstein N, Duran B. Community-based participatory research contributions to intervention research: The intersection of science and practice to improve health equity. Am J Public Health 2010;100 Suppl 1:S40-46.

[69] Minkler M. Community-based research partnerships: Challenges and opportunities. J Urban Health 2005;82:ii3-12.

[70] Kaufman A, Rhyne RL, Anastasoff J, Ronquillo F, Nixon M, Mishra S, Poola C, Page-Reeves J, Nkouaga C, Cordova C, Larson RS. Health extension and clinical and translational science: An innovative strategy for community engagement. J Am Board Fam Med 2017;30:94-99.

[71] Newman PA, Duan N, Roberts KJ, Seiden D, Rudy ET, Swendeman D, Popova S. Hiv vaccine trial participation among ethnic minority communities: Barriers, motivators, and implications for recruitment. J Acquir Immune Defic Syndr 2006;41:210-217.

[72] Horowitz CR, Brenner BL, Lachapelle S, Amara DA, Arniella G. Effective recruitment of minority populations through community-led strategies. Am J Prev Med 2009;37:S195-200.

[73] Bishop WP, Craddock Lee SJ, Skinner CS, Jones TM, McCallister K, Tiro JA. Validity of single-item screening for limited health literacy in english and spanish speakers. Am J Public Health 2016;106:889-892.

[74] Baxter J, Vehik K, Johnson SB, Lernmark B, Roth R, Simell T, Group TS. Differences in recruitment and early retention among ethnic minority participants in a large pediatric cohort: The teddy study. Contemp Clin Trials 2012;33:633-640.

[75] Cui Z, Seburg EM, Sherwood NE, Faith MS, Ward DS. Recruitment and retention in obesity prevention and treatment trials targeting minority or low-income children: A review of the clinical trials registration database. Trials 2015;16:564.

[76] Wiemann CM, Chacko MR, Tucker JC, Velasquez MM, Smith PB, DiClemente RJ, von Sternberg K. Enhancing recruitment and retention of minority young women in community-based clinical research. J Pediatr Adolesc Gynecol 2005;18:403-407.

[77] Zamora I, Williams ME, Higareda M, Wheeler BY, Levitt P. Brief report: Recruitment and retention of minority children for autism research. J Autism Dev Disord 2016;46:698-703.

[78] Johnson SB, Lynch KF, Lee HS, Smith L, Baxter J, Lernmark B, Roth R, Simell T, Group TS. At high risk for early withdrawal: Using a cumulative risk model to increase retention in the first year of the teddy study. J Clin Epidemiol 2014;67:609-611.

[79] Nicholson LM, Schwirian PM, Groner JA. Recruitment and retention strategies in clinical studies with low-income and minority populations: Progress from 2004-2014. Contemp Clin Trials 2015;45:34-40.

[80] Treweek S, Lockhart P, Pitkethly M, Cook JA, Kjeldstrom M, Johansen M, Taskila TK, Sullivan FM, Wilson S, Jackson C, Jones R, Mitchell ED. Methods to improve recruitment to randomised controlled trials: Cochrane systematic review and meta-analysis. BMJ Open 2013;3

[81] Caren Heller, Balls-Berry. JE, Jill Dumbauld Nery, Patricia J. Erwin, Dawn Littleton, Mimi Kim, Kuo WP. Strategies addressing barriers to clinical trial enrollment of underrepresented populations: A systematic review. Contemporary Clinical Trials 2014;39:169-182.

[82] Brueton VC, Tierney J, Stenning S, Harding S, Meredith S, Nazareth I, Rait G. Strategies to improve retention in randomised trials. Cochrane Database Syst Rev 2013:MR000032.

[83] Semba RD, Ricketts EP, Mehta SF, Kirk GD, Latkin C, Galai N, Vlahov D. Adherence and retention of female injection drug users in a phase iii clinical trial in inner city baltimore. Am J Drug Alcohol Abuse 2007;33:71-80.

[84] Annas GJ. Reforming informed consent to genetic research. JAMA 2001;286:2326-2328.

[85] Kadam RA. Informed consent process: A step further towards making it meaningful! . Perspectives in Clinical Research 2017;8:107-112.

[86] Ma GX, Tan Y, Blakeney NC, Seals BF, Ma XS, Zhai S, Liu A, Tai Y, Michaels M. The impact of a community-based clinical trial educational intervention among underrepresented chinese americans. Cancer Epidemiol Biomarkers Prev 2014;23:424-432.

[87] Matsui K, Kita Y, Ueshima H. Informed consent, participation in, and withdrawal from a population based cohort study involving genetic analysis. J Med Ethics 2005;31:385-392.

[88] Lynoe N, Sandlund M, Dahlqvist G, Jacobsson L. Informed consent: Study of quality of information given to participants in a clinical trial. BMJ 1991;303:610-613.

[89] Bonevski B, Randell M, Paul C, Chapman K, Twyman L, Bryant J, Brozek I, Hughes C. Reaching the hard-to-reach: A systematic review of strategies for improving health and medical research with socially disadvantaged groups. BMC Med Res Methodol 2014;14:42.

[90] Act NIoHNR. 1993,

[91] Tanner A, Kim SH, Friedman DB, Foster C, Bergeron CD. Barriers to medical research participation as perceived by clinical trial investigators: Communicating with rural and african american communities. J Health Commun 2015;20:88-96.

[92] U.S. Department of Education IoES. National assessment of adult literacy, 2003,

[93] Paul J. Hauptman, Richard J. Bookman, Heinig S. Advancing the research mission in a time of mergers and acquisitions. Journal of the American Medical Association 2017;318:1321-1322.

[94] Tishler CL, Bartholomae S. The recruitment of normal healthy volunteers: A review of the literature on the use of financial incentives. J Clin Pharmacol 2002;42:365-375.

[95] 95 Young SD. Social media technologies for hiv prevention study retention among minority men who have sex with men (msm). AIDS Behav 2014;18:1625-1629.